Group photo of awardees at the 2023 Research Excellence Awards.

2023 Research Excellence Awards

On Wednesday 27 March 2024, we honoured the achievements of Australian health and medical researchers who have dedicated their careers to improving the health of our nation, through our annual Research Excellence Awards.

Shining a light on chronic disease, suicide prevention, novel drug development and discovery, as well as improving health equity among Aboriginal and Torres Strait Islander communities, these awards acknowledged the top-ranked researchers and teams following peer review of applications to NHMRC’s highly competitive grant schemes in 2023.

 

Read about the 2023 Awards Recipients

Latest

Decorative
Media release
  • News
  • Driving a new era in Australian health and medical research

    The National Health and Medical Research Council (NHMRC) and the Medical Research Future Fund (MRFF) will work more closely under a new structure announced today.

    Communique
  • News
  • NHMRC update on the Australian Drinking Water Guidelines

    The National Health and Medical Research Council (NHMRC) plays a pivotal role in safeguarding public health by developing the Australian Drinking Water Guidelines (the Guidelines). These guidelines serve as a crucial resource for water regulators and suppliers, offering comprehensive advice on monitoring and managing drinking water quality across Australia.

    Professor Don at NHMRC’s Research Excellence Awards
    InFocus
  • Media release
  • Research Excellence: A new paradigm for how APOE genotype affects brain lipid homeostasis and dementia risk

    Professor Anthony Don is Professor of Medical Biochemistry in the School of Medical Sciences at the University of Sydney. His team develops and applies advanced mass spectrometry methods to investigate how alterations to brain lipid metabolism with ageing lead to dementia, develop neuroprotective therapeutics, and discover new biomarkers for demyelinating diseases. His research has uncovered deficits in lipid metabolism that destabilise myelin in the course of normal ageing and early in Alzheimer’s disease pathogenesis. He also developed and coordinates the popular masters-level unit of study, Advances in Disease Diagnosis and Treatment.